Related Experiment Video
Updated: Sep 27, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Clinical experience with cefotaxime in the treatment of patients with bacteremia
Abstract:
Seventy-three of 129 patients with bacteremia were observed for their responses to cefotaxime therapy. The clinical response to treatment with cefotaxime was satisfactory in 68 (93%) of the 73 patients. The bacteriologic response was satisfactory in 64 (92.7%) of the 69 patients with bacteriologic evidence of bacteremia. One hundred twenty-nine patients were observed for adverse reactions. Four patients had adverse reactions serious enough to warrant discontinuation of therapy, and three patients developed superinfections.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance